High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Bibtex

@article{714c3183b9d147e99ee684db50463dc2,
title = "High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy.",
abstract = "To assess the prognostic importance of high-sensitive C reactive protein (hsCRP) in patients with mild to moderate aortic valve stenosis during placebo or simvastatin/ezetimibe treatment in Simvastatin and Ezetimibe in Aortic Stenosis (SEAS).",
author = "Adam Blyme and Camilla Asferg and Nielsen, {Olav W} and Thomas Sehestedt and Kes{\"a}niemi, {Y Antero} and Christa Gohlke-B{\"a}rwolf and Kurt Boman and Ronnie Willenheimer and Simon Ray and Nienaber, {Christoph A} and Anne Rosseb{\o} and Kristian Wachtell and Olsen, {Michael H}",
year = "2015",
doi = "10.1136/openhrt-2014-000152",
language = "English",
volume = "2",
pages = "e000152",
journal = "Open Heart",
issn = "2053-3624",
publisher = "BMJ Publishing Group",
number = "1",

}